Mirabegron has longer treatment persistence than antimuscarinics: Real-world data from a Korean national cohort database.

Kyu-Sung LeeHyejeong ParkDanbee KangHye J ByunChee Yoong FooFarid A HadiSoyoung KimJuhee Cho

Published in: Neurourology and urodynamics (2021)

The results from the HIRA database showed that persistence was longer with mirabegron than with antimuscarinics in South Korea. This finding may help inform clinical decision-making within the South Korean healthcare system.

Keyphrases

decision making
adverse drug
quality improvement
big data
machine learning
data analysis
replacement therapy